Hot Pursuit     16-Apr-24
Caplin Point rises on USFDA nod for eye drops
Caplin Point Laboratories added 1.67% to Rs 1,318.75 after its subsidiary, Caplin Steriles received final approval from the US drug regulator for its abbreviated new drug application (ANDA) Ofloxacin Ophthalmic Solution.
The approved ANDA is a generic therapeutic equivalent version of reference listed drug (RLD), Ocuflox Ophthalmic Solution of Allergan Inc.

Ofloxacin Ophthalmic Solution (eye drops) is indicated for treatment of eye infections caused during the conditions of conjunctivitis and corneal ulcers.

According to IQVIA (IMS Health), Ofloxacin Ophthalmic Solution had US sales of approximately $52 million for the 12- month period ending December 2023.

Caplin Point Laboratories is a fast-growing pharmaceutical company with a unique business model catering predominantly to emerging markets of Latin America and Africa. The company has manufacturing facilities that cater to a complete range of finished dosage forms.

The company‘s consolidated net profit jumped 30.1% to Rs 119.82 crore on 17% increase in revenue from operations to Rs 435.50 crore in Q3 FY24 over Q3 FY23.

Previous News
  Benchmarks trades with small gains; media shares in demand
 ( Market Commentary - Mid-Session 19-Aug-24   10:33 )
  Volumes soar at Hindustan Zinc Ltd counter
 ( Hot Pursuit - 19-Aug-24   11:00 )
  Caplin Point Laboratories allots 68,550 equity shares under ESOS
 ( Corporate News - 19-Jun-24   14:17 )
  Volumes jump at Mphasis Ltd counter
 ( Hot Pursuit - 10-Jun-24   11:00 )
  Caplin Point hits life high after Chennai unit clears Brazilian Agency’s inspection
 ( Hot Pursuit - 19-Aug-24   09:46 )
  Caplin Point Laboratories Ltd leads gainers in 'A' group
 ( Hot Pursuit - 19-Aug-24   12:00 )
  Caplin Point Laboratories consolidated net profit rises 20.23% in the December 2023 quarter
 ( Results - Announcements 09-Feb-24   14:30 )
  Caplin Steriles receives USFDA approval for Phenylephrine hydrochloride Ophthalmic solution
 ( Corporate News - 24-May-24   12:26 )
  Caplin Point Laboratories consolidated net profit rises 25.31% in the September 2023 quarter
 ( Results - Announcements 09-Nov-23   14:01 )
  Caplin Steriles receives USFDA approval for Ofloxacin Ophthalmic Solution USP 0.3%
 ( Corporate News - 16-Apr-24   11:32 )
  Caplin Point Laboratories consolidated net profit rises 30.06% in the December 2022 quarter
 ( Results - Announcements 11-Feb-23   15:15 )
Other Stories
  KRN Heat Exchanger makes stellar debut
  03-Oct-24   10:31
  Maruti Suzuki total sales rises to 1,84,727 units in Sep’24
  03-Oct-24   10:12
  Metal shares gain
  03-Oct-24   10:00
  Basic materials shares gain
  03-Oct-24   10:00
  Telecom shares rise
  03-Oct-24   10:00
  JSW Steel Ltd Spikes 1.87%
  03-Oct-24   09:30
  Eicher Motors Ltd Falls 3.14%, BSE Auto index Drops 2.14%
  03-Oct-24   09:30
  Adani Ports records 14% YoY growth in Sept'24 cargo volumes
  03-Oct-24   09:29
  NMDC iron ore production rises YoY to 3.04 MT in Sept'24
  03-Oct-24   08:38
  Tata Motors total sales drop 11% YoY in Sept’24
  01-Oct-24   15:33
Back Top